News
-
-
COMMUNIQUÉ DE PRESSE
TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024
TVM Capital Life Science to participate in LSI USA '24 Emerging Medtech Summit 2024, showcasing industry trends & partnerships. Dr. Luc Marengère & Dr. Sascha Berger to speak on medtech innovation & AI adoption -
COMMUNIQUÉ DE PRESSE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology -
COMMUNIQUÉ DE PRESSE
TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP
TVM Capital Life Science invests €8 million in Myosotis GmbH to revolutionize elderly care with innovative app, strengthening healthcare communication and administrative processes in care homes -
-
COMMUNIQUÉ DE PRESSE
TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
-
-
-